Novartis Pharma
Asia, Tokyo, Japan, Tokyo
Description
Novartis Pharma is the Japanese subsidiary of Novartis Pharmaceuticals, a world-leading healthcare company based in Basel, Switzerland
Investor Profile
Novartis Pharma has backed more than 7 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series B, Post Ipo Equity rounds (top funding stages).
- Majority of deals are located in United States, Germany.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
Stage Focus
- Series C (43%)
- Series B (29%)
- Post Ipo Equity (14%)
- Series A (14%)
Country Focus
- United States (86%)
- Germany (14%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical Device
- Cloud Computing
- Enterprise Software
- Software
- Health Diagnostics
- Artificial Intelligence (Ai)
- Biopharma
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
